Newswise — A molecule involved in fat transport and metabolism is key to the progression of the malignant blood cancer multiple myeloma, researchers report today in
.
The molecule – called fatty acid binding protein 5 (FABP5) – could be used as a marker to help doctors identify people with more aggressive forms of myeloma and may represent a new target for multiple myeloma treatment, which is urgently needed.
Multiple myeloma accounts for roughly 10% of blood cancers and only around half of people who develop the disease will live beyond five years.